Sebastiaan W F van Meyel
Overview
Explore the profile of Sebastiaan W F van Meyel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
58
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Meyel S, Verdijk R, Therssen N, Paridaens D
Ophthalmic Plast Reconstr Surg
. 2024 Jul;
40(6):e230-e232.
PMID: 39077973
Nerve sheath myxomas are extremely rare myxoid peripheral nerve sheath tumors with a predilection for the distal extremities, particularly common in the fingers and knees. Here, the authors report a...
2.
Coopmans E, Postma M, Wolters T, van Meyel S, Netea-Maier R, van Beek A, et al.
J Clin Endocrinol Metab
. 2021 Feb;
106(6):1783-1792.
PMID: 33544833
Context: Transsphenoidal surgery (TSS) is the primary treatment of choice in acromegaly. It is important to identify patients in whom surgical cure is not attainable at an early stage, both...
3.
Coopmans E, Korevaar T, van Meyel S, Daly A, Chanson P, Brue T, et al.
J Clin Endocrinol Metab
. 2020 Jun;
105(9).
PMID: 32589751
Context: First-generation somatostatin receptor ligands (fg-SRLs) represent the mainstay of medical therapy for acromegaly, but they provide biochemical control of disease in only a subset of patients. Various pretreatment biomarkers...
4.
Coopmans E, van Meyel S, van der Lely A, Neggers S
Arch Endocrinol Metab
. 2020 Jan;
63(6):646-652.
PMID: 31939490
Advances in combination medical treatment have offer new perspectives for acromegaly patients with persistent disease activity despite receiving the available medical monotherapies. The outcomes of combination medical treatment may reflect...
5.
Coopmans E, van Meyel S, Pieterman K, van Ipenburg J, Hofland L, Donga E, et al.
Eur J Endocrinol
. 2019 Jun;
181(2):K21-K27.
PMID: 31167168
Prolactinomas are the most commonly encountered pituitary adenomas in the clinical setting. While most can be controlled by dopamine agonists, a subset of prolactinomas are dopamine-resistant and very aggressive. In...